These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 35915417)

  • 1. Long COVID headache.
    Tana C; Bentivegna E; Cho SJ; Harriott AM; García-Azorín D; Labastida-Ramirez A; Ornello R; Raffaelli B; Beltrán ER; Ruscheweyh R; Martelletti P
    J Headache Pain; 2022 Aug; 23(1):93. PubMed ID: 35915417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long COVID and especially headache syndromes.
    Tana C; Giamberardino MA; Martelletti P
    Curr Opin Neurol; 2023 Jun; 36(3):168-174. PubMed ID: 37078648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronavirus Disease 2019, Eye Pain, Headache, and Beyond.
    Landis BC; Brooks AE; Digre KB; Seay MD
    J Neuroophthalmol; 2022 Mar; 42(1):18-25. PubMed ID: 35051986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research.
    Caronna E; Pozo-Rosich P
    Curr Pain Headache Rep; 2021 Nov; 25(11):73. PubMed ID: 34766205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a better understanding of persistent headache after mild COVID-19: Three migraine-like yet distinct scenarios.
    Caronna E; Alpuente A; Torres-Ferrus M; Pozo-Rosich P
    Headache; 2021 Sep; 61(8):1277-1280. PubMed ID: 34363619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review.
    Caronna E; van den Hoek TC; Bolay H; Garcia-Azorin D; Gago-Veiga AB; Valeriani M; Takizawa T; Messlinger K; Shapiro RE; Goadsby PJ; Ashina M; Tassorelli C; Diener HC; Terwindt GM; Pozo-Rosich P
    Cephalalgia; 2023 Jan; 43(1):3331024221131337. PubMed ID: 36606562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case-control study.
    Magdy R; Elmazny A; Soliman SH; Elsebaie EH; Ali SH; Abdel Fattah AM; Hassan M; Yassien A; Mahfouz NA; Elsayed RM; Fathy W; Abdel-Hamid HM; Mohamed J; Hussein M
    J Headache Pain; 2022 Aug; 23(1):101. PubMed ID: 35962348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protracted headache after COVID-19: A case series of 31 patients from a tertiary headache center.
    Moskatel LS; Smirnoff L
    Headache; 2022 Jul; 62(7):903-907. PubMed ID: 35670231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New daily persistent headache after SARS-CoV-2 infection: a report of two cases.
    Dono F; Consoli S; Evangelista G; D'Apolito M; Russo M; Carrarini C; Calisi D; De Rosa M; Di Pietro M; De Angelis MV; Travaglini D; Sensi SL; Onofrj M; Bonanni L
    Neurol Sci; 2021 Oct; 42(10):3965-3968. PubMed ID: 34264414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study.
    Fernández-de-Las-Peñas C; Gómez-Mayordomo V; Cuadrado ML; Palacios-Ceña D; Florencio LL; Guerrero AL; García-Azorín D; Hernández-Barrera V; Arendt-Nielsen L
    Cephalalgia; 2021 Nov; 41(13):1332-1341. PubMed ID: 34134526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19.
    Messlinger K; Neuhuber W; May A
    Cephalalgia; 2022 Feb; 42(2):176-180. PubMed ID: 34407648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Headache in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Narrative Review.
    Tolebeyan AS; Zhang N; Cooper V; Kuruvilla DE
    Headache; 2020 Nov; 60(10):2131-2138. PubMed ID: 33017479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New-onset headache following COVID-19: An Italian multicentre case series.
    Torrente A; Alonge P; Di Stefano V; Baschi R; Ornello R; Correnti E; Lupica A; Camarda C; Farinella G; Raieli V; Sacco S; Monastero R; Brighina F
    J Neurol Sci; 2023 Mar; 446():120591. PubMed ID: 36807975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Headache associated with COVID-19: Epidemiology, characteristics, pathophysiology, and management.
    Sampaio Rocha-Filho PA
    Headache; 2022 Jun; 62(6):650-656. PubMed ID: 35545780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant.
    Fernández-de-Las-Peñas C; Cuadrado ML; Gómez-Mayordomo V; García-Azorín D; Arendt-Nielsen L
    Expert Rev Neurother; 2023 Feb; 23(2):179-186. PubMed ID: 36857191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review.
    Mitsikostas DD; Caronna E; De Tommaso M; Deligianni CI; Ekizoglu E; Bolay H; Göbel CH; Kristoffersen ES; Lampl C; Moro E; Pozo-Rosich P; Sellner J; Terwindt G; Irimia-Sieira P
    Eur J Neurol; 2024 Jun; 31(6):e16251. PubMed ID: 38415282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of new or more severe headaches following COVID-19 is associated with markers of microglial activation and peripheral sensitization: results from a prospective cohort study.
    Ruhnau J; Blücher M; Bahlmann S; Zieme A; Vogelgesang A; Steinmetz A; Fleischmann R
    J Headache Pain; 2024 Jun; 25(1):101. PubMed ID: 38890625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus disease-19 and headache; impact on pre-existing and characteristics of de novo: a cross-sectional study.
    Al-Hashel JY; Abokalawa F; Alenzi M; Alroughani R; Ahmed SF
    J Headache Pain; 2021 Aug; 22(1):97. PubMed ID: 34418950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-COVID Headache: A Literature Review.
    Chhabra N; Grill MF; Singh RBH
    Curr Pain Headache Rep; 2022 Nov; 26(11):835-842. PubMed ID: 36197571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of COVID-19 on chronic migraine treated with erenumab: a case report.
    Grassini A; Marcinnò A; Roveta F; Gallo E; Cermelli A; Boschi S; Rubino E; Rainero I
    Neurol Sci; 2021 Aug; 42(8):3079-3081. PubMed ID: 34021438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.